Regulatory Open Forum

 View Only
  • 1.  Clinical Evaluation Report Frequency

    This message was posted by a user wishing to remain anonymous
    Posted 21-Feb-2023 10:44
    This message was posted by a user wishing to remain anonymous

    Under the EUMDR, is it up to the manufacturer to establish the frequency of which CERs are updated?  Is it the same for all device classifications?  Where is this defined?  Is there flexibility?

    Thanks in advance btw



  • 2.  RE: Clinical Evaluation Report Frequency

    Posted 21-Feb-2023 11:12

    Hi,

    Clause 6.2.3 requires the CER to be updated at least annually for high risk or new devices, and every 2 to 5 years for lower risk, well-established devices. A justification for the frequency of updates will be required. For all risk classifications of devices, the CER will need to be updated whenever new information from the Post Market Surveillance (PMS) affects the evaluation or its conclusions. 



    ------------------------------
    Raje Devanathan
    Amerisource Bergen
    TPIreg, Innomar Strategies
    Senior Manager - Regulatory Affairs, Medical Devices
    rdevanathan@tpireg.com
    3470 Superior Court
    Oakville ON L6L0C4
    Canada
    ------------------------------



  • 3.  RE: Clinical Evaluation Report Frequency

    This message was posted by a user wishing to remain anonymous
    Posted 21-Feb-2023 13:07
    This message was posted by a user wishing to remain anonymous

    Thank you!  Are we still able to use the MEDDEV guidance under MDR?  Does anything in the EU MDR supersede 6.2.3?




  • 4.  RE: Clinical Evaluation Report Frequency

    Posted 21-Feb-2023 14:58

    The EU MDR doesn't prescribe the frequency at which CERs are to be updated.  Modeling this, the MDCG (2020-13) has left manufacturers the liberty to, "...Identify when updates to the clinical evaluation report shall be assessed during the surveillance and post certification monitoring activities and which frequency should be considered...".  Consequently, yes, the frequency of updates is generally up to the manufacturer's discretion. Yet that must be appropriate risk-based discretion.

    While MEDDEV 2.7/1 revision 4 gives specific guidelines (specifically, update at least annually if the device carries significant risks or is not yet well established; or every 2 to 5 years if the device is not expected to carry significant risks and is well established), we need to remain sensitive to the fact that MEDDEV 2.7/1 isn't generally intended for the EU MDR.  Nonetheless, for now, the Notified Bodies and other Union authorities are still often generally tolerant of that MEDDEV in my experience as along as its prescription is reasonable for the subject device.  Otherwise, the manufacturer is required to tailor the frequencies to its particular device scenario.



    ------------------------------
    Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright 2023 by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 5.  RE: Clinical Evaluation Report Frequency

    Posted 22-Feb-2023 03:25

    Just to add further comment to what has been provided, the updating of a clinical evaluation file should (needs to) coincide with many other files within the aspects of EU MDR (and the same holds true for Performance Evaluation under the EU IVDR).  When updating the clinical evaluation other processes need to be considered such as design changes, risk management, post market, manufacturing updates, etc.  Be aware of just putting in a "annual" or "every 2 years" update/review of the clinical evaluation needs to also include "triggers" for when a review of the benefit/risk for a device needs to be performed outside of a standard review cycle, e.g. changes to indications for use.



    ------------------------------
    Richard Vincins ASQ-CQA, MTOPRA, RAC
    Vice President Global Regulatory Affairs
    ------------------------------



  • 6.  RE: Clinical Evaluation Report Frequency

    Posted 23-Feb-2023 02:15
    Edited by Stephanie Grassmann 23-Feb-2023 02:16

    Dear Anon

     

    The MEDDEV 2.7/1 (Rev 4) appears on the MDCG endorsed documents web site (Medical Device Coordination Group established under the MDR).

    Further information and the link to this document is found here:

    https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en<o:p></o:p>

    Presently, some manufacturers make a proposal to their notified body on the frequency of CER updates with the rationale i.e. well established technology, etc.. For instance, updating a CER every three to five years for well established class IIB or III has been accepted by some notified bodies. Other notified bodies may ask that the CER update coincides with the PSUR. Maybe there will a MDCG in the future on this topic.

    Best Regards,

    Stephanie



    ------------------------------
    Stephanie Grassmann
    Founder & Managing Director of MedTechXperts Ltd
    Biberstein
    Switzerland
    ------------------------------



  • 7.  RE: Clinical Evaluation Report Frequency

    This message was posted by a user wishing to remain anonymous
    Posted 24-Feb-2023 08:29
    This message was posted by a user wishing to remain anonymous

    This is great feedback!  I work with a lot of well established IIB devices and 3 to 5 years makes a lot of sense to me.  Thank you!




  • 8.  RE: Clinical Evaluation Report Frequency

    Posted 24-Feb-2023 09:19

    Dear Anon,

    maybe one additional remark: While there is no fixed update schedule for the CER in the MDR, there are mandatory minimum intervals for the generation of PSURs (every 2 years for class IIa and annually for class IIb/III) and PMCF evaluation reports (annually for class III and implantable devices). It probably makes sense to consider how these might contribute to regular updates of the CER as well as (like Richard said above) trigger the need for additional updates.

    Best regards

    Christoph 



    ------------------------------
    Christoph Kiesselbach
    Reutlingen
    Germany
    ------------------------------